Thursday, November 14, 2013

In addition, the risk of infection associated with certain viruses that may be contained in the mat


November flow cytometry 28 news Reuters reported with reference flow cytometry to the FDA website flow cytometry that management flow cytometry has recognized the drug Creon / Kreon company Solvay SA safe and effective in the short term.
A major concern associated with the preparation Creon and similar products, due to the fact that the pancreatic enzymes from the pancreas of pigs, which can be a potential cause of human transmission of virus from an infected animal is possible.
Therefore, on December 2nd FDA advisory committee planned to discuss what steps should be taken in order to reduce flow cytometry the risk of virus transmission when receiving enzymatic means, such as Creon. In the control point that traces neutralization of viruses during the production of the drug may also reduce the activity of proteolytic enzymes. flow cytometry
In addition, the risk of infection associated with certain viruses that may be contained in the material for the drug Creon, is low, but it can be reduced by additional testing. FDA also plans to consult with a group of experts as to what types of viruses should be tested material from which made Creon, and what criteria should be used in the manufacture of each batch of the drug. In Solvay is also noted that the company is taking special measures, such as screening of a ready product to reduce the possibility of transmission.
Solvay has also applied flow cytometry to the use of this drug in adults and children, which was based on a study of use of Creon in 32 patients aged 12-43 years with cystic fibrosis flow cytometry (CF) of the pancreas. According to FDA, Creon effective for reducing gastrointestinal symptoms in patients with cystic fibrosis, and in the short term, makes a high safety, since in the course of clinical studies more side effects observed in the placebo group. Regarding the use of Creon in children younger than 12 years, FDA advisory committee awaiting a decision on this matter, as in a clinical trial included patients aged 12 years and older.
Currently, as the Solvay , the company is conducting a study on the drug Creon in children aged 6-11 years and is scheduled to begin trial in infants.
Fields marked with an asterisk are required Your Name * Rules of commenting comment to be published after moderation edition flow cytometry of the publication. We reserve the right not to publish posts that are irrelevant to the material and the topic of discussion. Certainly not: - profanity. - Comments that defame the reputation of companies, organizations, products, insults resource users, authors or participants articles. - Incitement to ethnic, religious or other hatred, incitement to unlawful acts; - advertising - posting links to other resources without the consent of a site moderator. E-Mail * Position, flow cytometry Message * Subscribe to new posts Colleagues Filling the example field is required to post comments and is designed to protect Internet resources from spam (junk e-mail messages).
Enter numbers shown in the image * Other articles in this section [11/14/2013 13:08] To drink or not to drink: a sense of proportion is welcome [11/08/2013 20:48] As a balm to the soul: treat colds rationally [2013-11 -08 19:49] Anti-depressants and sedatives. Two different paths to spiritual harmony [2013-11-08 17:10] DRY DRY - your assistant in extreme situations [11/08/2013 17:06] What are the horns of a person? [11/08/2013 15:03] Natural pharmacy, or What you did not know about garlic [11/07/2013 17:56] cedar oil: in harmony with nature! flow cytometry [11/07/2013 flow cytometry 12:33] Absorbent articles Seni - comfort and confidence at any age [07/11/2013 11:13] Seasonal assortment flow cytometry of TM Hirudo Derm: protection and comfort regardless of the weather outside the window [2013-11-01 10:38] Sea buckthorn oil - a storehouse of vitamins! Latest News and Articles [14/11/2013 18:01] In the U.S., the development stage is 452 candidate drugs for the treatment of rare diseases [14/11/2013 13:08] To drink or not to drink: a sense of proportion is welcome [2013-11 -14 13:01] Reforming the health care system in Ukraine: realities and prospects [14/11/2013 12:37] List od 13.11.2013 p. 24533-1.3/2.0/17-13 [2013-11-14 12:37] flow cytometry List od 12.11.2013 p. 24490-1.3/2.2/17-13 [2013-11-14 12:37] List od 12.11.2013 p. 24489-1.3/2.1/17-13 [2013-11-14 12:36] List od 12.11.2013 flow cytometry p. 24487-1.3/2.1/17-13 [2013-11-14 flow cytometry 12:36] List od 12.11.2013 p. 24486-1.3/2.1/17-13 flow cytometry [2013-11-14 12:36] List od 12.11.2013 p. 24483-1.3/2.1/17-13 [2013-11-14 12:35] List od 12.11.2013 p. 24482-1.3/2.2/17-13 Drugs, medicines and drug prices and all n

No comments:

Post a Comment